PharmaShots | Incisive News in 3 Shots

Subscribe Now

Shanghai Taiyin Biotechnology

Shanghai Taiyin Biotechnology Reports Preclinical Study of Omalizumab Biosimilar KA

Shanghai Taiyin Biotechnology Reports Preclinical Study of Omalizumab Biosimilar KA

February 11, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us